Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulixertinib in advanced malignancies
NCT01781429Phase 2Completed
- Sponsor
- BioMed Valley Discoveries
- Start
- Mar 2013
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ulixertinib in solid tumor (advanced stage), sponsored by BioMed Valley Discoveries. Started Mar 2013; status: completed.
02
Drugs
ulixertinib
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT01781429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01781429.